{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T17:01:52Z","timestamp":1793466112606,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"S.K. Yee Medical Foundation","award":["2141219"],"award-info":[{"award-number":["2141219"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinica Chimica Acta"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/j.cca.2017.03.022","type":"journal-article","created":{"date-parts":[[2017,3,23]],"date-time":"2017-03-23T15:04:14Z","timestamp":1490281454000},"page":"63-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Global developmental delay and intellectual disability associated with a de novo TOP2B mutation"],"prefix":"10.1016","volume":"469","author":[{"given":"Ching-wan","family":"Lam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wai-lan","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-yiu","family":"Law","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cca.2017.03.022_bb0005","doi-asserted-by":"crossref","first-page":"R24","DOI":"10.1093\/hmg\/ddv273","article-title":"Genetics and genomics of autism spectrum disorder: embracing complexity","volume":"24","author":"De Rubeis","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.cca.2017.03.022_bb0010","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.pcl.2015.03.003","article-title":"Diagnosis and management of autism spectrum disorder in the era of genomics: rare disorders can pave the way for targeted treatments","volume":"62","author":"Baker","year":"2015","journal-title":"Pediatr. Clin. N. Am."},{"key":"10.1016\/j.cca.2017.03.022_bb0015","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/gim.2013.32","article-title":"Clinical genetics evaluation in identifying the etiology of autism spectrum disorders: 2013 guideline revisions","volume":"15","author":"Schaefer","year":"2013","journal-title":"Genet. Med."},{"key":"10.1016\/j.cca.2017.03.022_bb0020","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.brainres.2010.11.078","article-title":"Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting","volume":"1380","author":"Betancur","year":"2011","journal-title":"Brain Res."},{"key":"10.1016\/j.cca.2017.03.022_bb0025","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.neuron.2012.04.009","article-title":"De novo gene disruptions in children on the autistic spectrum","volume":"74","author":"Iossifov","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.cca.2017.03.022_bb0030","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/nn.3703","article-title":"Prioritization of neurodevelopmental disease genes by discovery of new mutations","volume":"17","author":"Hoischen","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.cca.2017.03.022_bb0035","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.tins.2013.11.005","article-title":"A de novo convergence of autism genetics and molecular neuroscience","volume":"37","author":"Krumm","year":"2014","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.cca.2017.03.022_bb0040","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1136\/jmedgenet-2013-101519","article-title":"From the periphery to centre stage: de novo single nucleotide variants play a key role in human genetic disease","volume":"50","author":"Ku","year":"2013","journal-title":"J. Med. Genet."},{"key":"10.1016\/j.cca.2017.03.022_bb0045","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/nrg3241","article-title":"De novo mutations in human genetic disease","volume":"13","author":"Veltman","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.cca.2017.03.022_bb0050","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1111\/epi.12554","article-title":"Exome sequencing identifies a de novo SCN2A mutation in a patient with intractable seizures, severe intellectual disability, optic atrophy, muscular hypotonia, and brain abnormalities","volume":"55","author":"Baasch","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.cca.2017.03.022_bb0055","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nm.3792","article-title":"Whole-genome sequencing of quartet families with autism spectrum disorder","volume":"21","author":"Yuen","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.cca.2017.03.022_bb0060","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1007\/s10803-015-2484-8","article-title":"Brief report: SETD2 mutation in a child with autism, intellectual disabilities and epilepsy","volume":"45","author":"Lumish","year":"2015","journal-title":"J. Autism Dev. Disord."},{"key":"10.1016\/j.cca.2017.03.022_bb0065","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/cge.12277","article-title":"A homozygous mutation in a consanguineous family consolidates the role of ALDH1A3 in autosomal recessive microphthalmia","volume":"86","author":"Roos","year":"2014","journal-title":"Clin. Genet."},{"key":"10.1016\/j.cca.2017.03.022_bb0070","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.ajhg.2013.06.012","article-title":"Detection of clinically relevant genetic variants in autism spectrum disorder by whole-genome sequencing","volume":"93","author":"Jiang","year":"2013","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.cca.2017.03.022_bb0075","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.cca.2017.03.022_bb0080","article-title":"Distinct expression patterns for type II topoisomerases IIA and IIB in the early foetal human telencephalon","author":"Harkin","year":"2015","journal-title":"J. Anat."},{"key":"10.1016\/j.cca.2017.03.022_bb0085","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1126\/science.287.5450.131","article-title":"DNA topoisomerase IIbeta and neural development","volume":"287","author":"Yang","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.cca.2017.03.022_bb0090","doi-asserted-by":"crossref","first-page":"7929","DOI":"10.1128\/MCB.00617-06","article-title":"Role of topoisomerase IIbeta in the expression of developmentally regulated genes","volume":"26","author":"Lyu","year":"2006","journal-title":"Mol. Cell. Biol."},{"key":"10.1016\/j.cca.2017.03.022_bb0095","doi-asserted-by":"crossref","first-page":"7123","DOI":"10.1073\/pnas.1232376100","article-title":"Aberrant lamination in the cerebral cortex of mouse embryos lacking DNA topoisomerase IIbeta","volume":"100","author":"Lyu","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.cca.2017.03.022_bb0100","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1007\/s12264-010-0625-9","article-title":"The function of DNA topoisomerase IIbeta in neuronal development","volume":"26","author":"Heng","year":"2010","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.cca.2017.03.022_bb0105","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s00277-014-2209-7","article-title":"DNA topoisomerase IIbeta as a molecular switch in neural differentiation of mesenchymal stem cells","volume":"94","author":"Isik","year":"2015","journal-title":"Ann. Hematol."},{"key":"10.1016\/j.cca.2017.03.022_bb0110","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/nature12504","article-title":"Topoisomerases facilitate transcription of long genes linked to autism","volume":"501","author":"King","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.cca.2017.03.022_bb0115","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002627","article-title":"Increased gene dosage of Ube3a results in autism traits and decreased glutamate synaptic transmission in mice","volume":"3","author":"Smith","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.cca.2017.03.022_bb0120","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/nature07953","article-title":"Autism genome-wide copy number variation reveals ubiquitin and neuronal genes","volume":"459","author":"Glessner","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.cca.2017.03.022_bb0125","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.nbd.2008.08.011","article-title":"The comorbidity of autism with the genomic disorders of chromosome 15q11.2-q13","volume":"38","author":"Hogart","year":"2010","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.cca.2017.03.022_bb0130","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/nature10726","article-title":"Topoisomerase inhibitors unsilence the dormant allele of Ube3a in neurons","volume":"481","author":"Huang","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.cca.2017.03.022_bb0135","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/nature13975","article-title":"Towards a therapy for Angelman syndrome by targeting a long non-coding RNA","volume":"518","author":"Meng","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.cca.2017.03.022_bb0140","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.cell.2015.06.045","article-title":"An autism-linked mutation disables phosphorylation control of UBE3A","volume":"162","author":"Yi","year":"2015","journal-title":"Cell"}],"container-title":["Clinica Chimica Acta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898117300980?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009898117300980?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T04:25:18Z","timestamp":1535948718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009898117300980"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,6]]},"references-count":28,"alternative-id":["S0009898117300980"],"URL":"https:\/\/doi.org\/10.1016\/j.cca.2017.03.022","relation":{},"ISSN":["0009-8981"],"issn-type":[{"value":"0009-8981","type":"print"}],"subject":[],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global developmental delay and intellectual disability associated with a de novo TOP2B mutation","name":"articletitle","label":"Article Title"},{"value":"Clinica Chimica Acta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cca.2017.03.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}